Article
The efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy compared with conventional antiplatelet therapy in patients with acute coronary syndrome or undergoing percutaneous coronary intervention: A meta-analysis of randomized controlled trials.
Platelets - 16 Nov 2020
Lyu Si-Qi, Yang Yan-Min, Zhu Jun, Wang Juan, Wu Shuang, Zhang Han, Shao Xing-Hui, Ren Jia-Meng
Abstract excerpt
Cytochrome P450 (CYP) 2C19 genotype is closely associated with the metabolism and efficacy of clopidogrel, thereby having an important impact on clinical outcomes of patients with acute coronary syndrome (ACS) or undergoing percutaneous coronary intervention (PCI). This study aimed to evaluate the efficacy and safety of CYP2C19 genotype-guided antiplatelet therapy in patients with ACS or undergoing PCI. PubMed,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.